Importantly, each of these alterations not only drives malignant progression directly but also cooperated with aberrant B-cell receptor (BCR) signaling, a central axis of CLL biology and a critical force in the pathogenesis of RT [24]. Here, BCR is linked to B-cell chronic lymphocytic leukemia.